Endometrial intraepithelial neoplasia
Endometrial Intraepithelial Neoplasia[edit | edit source]
.jpg)
Endometrial intraepithelial neoplasia (EIN) is a precancerous condition of the endometrium, the lining of the uterus. It is characterized by an abnormal proliferation of the endometrial glands, which can lead to the development of endometrial cancer. EIN is considered a precursor lesion to endometrioid endometrial carcinoma, the most common type of endometrial cancer.
Pathophysiology[edit | edit source]
EIN arises due to genetic and hormonal factors that lead to the abnormal growth of endometrial cells. One of the key genetic alterations associated with EIN is the inactivation of the PTEN tumor suppressor gene. This inactivation results in unregulated cell proliferation and increased risk of progression to cancer.
The condition is often associated with prolonged exposure to estrogen without the counterbalancing effect of progesterone, which can occur in conditions such as polycystic ovary syndrome (PCOS), obesity, and estrogen replacement therapy without progesterone.
Diagnosis[edit | edit source]
The diagnosis of EIN is typically made through endometrial biopsy or dilation and curettage (D&C). Histopathological examination reveals glandular crowding, architectural complexity, and cytological atypia. Immunohistochemical staining for PTEN can aid in the diagnosis by demonstrating loss of PTEN expression in the affected tissue.
Treatment[edit | edit source]
Management of EIN involves addressing the underlying hormonal imbalance and may include the use of progestin therapy to counteract the effects of estrogen. In cases where there is a high risk of progression to cancer, surgical intervention such as hysterectomy may be recommended.
Prognosis[edit | edit source]
The prognosis for patients with EIN depends on the timely diagnosis and appropriate management of the condition. With effective treatment, the risk of progression to endometrial cancer can be significantly reduced.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
